Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:21 AM
Ignite Modification Date:
2025-12-25 @ 2:21 AM
NCT ID:
NCT05804734
Eligibility Criteria:
Inclusion Criteria:
* Cases :
* Males at any ages with hemophilia of any severity and of any type,
* Patients having received or receiving a long-term anticoagulant treatment (during at least 6 consecutive months) during the period from 2012 to 2021,
* Regular follow-up in a hemophilia treatment center.
* Controls : patients with hemophilia cross-matched with cases on:
* Age (+/- 5 years),
* Hemophilia type (either A or B)
* Hemophilia severity (for mild hemophilia: same basal factor level +/- 5%),
* HAS-BLED score (same score +/- 1).
Exclusion Criteria:
* Lost to medical follow-up,
* Refusal to participate in the study,
* Unable to understand the study's French letter of non-opposition and information.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
85 Years
Study:
NCT05804734
Study Brief:
Protocol Section:
NCT05804734